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Sequence polymorphisms linked to human dis-
eases and phenotypes in genome-wide association
studies often affect noncoding regions. A SNP
within an intron of the gene encoding Interferon
Regulatory Factor 4 (IRF4), a transcription factor
with no known role in melanocyte biology, is
strongly associated with sensitivity of skin to sun
exposure, freckles, blue eyes, and brown hair color.
Here, we demonstrate that this SNP lies within an
enhancer of IRF4 transcription in melanocytes.
The allele associated with this pigmentation pheno-
type impairs binding of the TFAP2A transcription
factor that, together with the melanocyte master
regulator MITF, regulates activity of the enhancer.
Assays in zebrafish and mice reveal that IRF4
cooperates with MITF to activate expression of
Tyrosinase (TYR), an essential enzyme in melanin
synthesis. Our findings provide a clear example of
a noncoding polymorphism that affects a pheno-1022 Cell 155, 1022–1033, November 21, 2013 ª2013 Elsevier Inc.type by modulating a developmental gene regula-
tory network.INTRODUCTION
Human pigmentation is a complex process involving melano-
cytes that synthesize the pigment melanin in melanosomes,
cell organelles that are transferred to neighboring keratinocytes,
where they form a cap over nuclei, thus protecting them from
negative effects of UV radiation (UVR). Pigmentation is not only
one of the most distinguishing features of humans but also
serves an important protective role. In humans, pigmentation de-
creases with increasing distance from the equator, presumably
due to a balance between the pressure to optimize the amount
of available UVR for the generation of vitamin D3 and the protec-
tion from UVR-mediated damage, which may result in increased
risk of cutaneous malignancies. This has led to positive selection
for less-pigmented skin, hair, and eyes in areas distant from the
equator. The major difference between dark- and light-skinned
individuals is due to differences in the number, size, and density
of the melanin-containing melanosomes; the number of melano-
cytes is roughly the same (reviewed in Sturm, 2009).
The genetics of pigmentation is complex and involves several
genes and pathways. It has been best characterized in the
mouse where 171 of nearly 400 loci implicated in pigmentation
have been functionally characterized (http://www.espcr.org/
micemut/). These pigmentation genes affect various steps in
the formation of melanocytes from the neural crest (e.g., Mgf,
Kit, and Mitf), the generation of components of melanosomes
and pigment (e.g., pMel17/Silver and Tyr), or the transport of me-
lanosomes alongmicrotubules in the dendrites before delivery to
adjacent keratinocytes (e.g., MyoVa, Rab27, and Mlph). Most
genes involved in pigmentation are transcriptionally regulated
by the bHLHZip transcription factor MITF, the master regulator
of melanocytes (reviewed in Steingrı´msson et al., 2004).
Genome-wide association studies (GWASs) have identified
several SNPs involved in human pigmentation, including SNPs
on chromosome 6 near the DUSP22, Interferon Regulatory
Factor 4 (IRF4), and EXOC2 genes, none of which was previously
implicated in pigmentation (Sulem et al., 2007, 2008; Han et al.,
2008). The SNP showing the strongest association is located in
intron 4 of IRF4 (Han et al., 2008). IRF4 belongs to the Interferon
Regulatory Factors (IRFs), a wing-helix-turn-helix family of tran-
scription factors that regulate interferon (IFN)-inducible genes
(Paun and Pitha, 2007). Although IRF4 does not depend on IFN
stimulation, it binds to the IFN-stimulated response element
(ISRE) within IFN-responsive genes (Grossman et al., 1996;
Escalante et al., 1998). Irf4mutantmice completely lack germinal
centers and plasma cells and show severely reduced immuno-
globulin levels in the serum; no defects in pigmentation were re-
ported (Mittru¨cker et al., 1997). In a subset of multiple patients
with myeloma, IRF4 is translocated downstream of the immuno-
globulin heavy-chain regulatory regions (Iida et al., 1997; Tsuboi
et al., 2000). Interestingly, in this disease, IRF4 acts as a lineage
survival oncogene regardless of translocation status (Shaffer
et al., 2008). Polymorphisms in the IRF4 gene are associated
with chronic lymphocytic leukemia (CLL) (Di Bernardo et al.,
2008) and with nonhematopoietic diseases, including celiac dis-
ease (Dubois et al., 2010), and progressive supranuclear palsy
(Ho¨glinger et al., 2011). Finally, IRF4 was recently shown to be
critical for transcriptional response to nutrient availability in adi-
pocytes (Eguchi et al., 2011).
A few reports have linked IRF4 to pigment cells. IRF4 is
expressed in melanocytes in the skin and in the G361 melanoma
cell line (Grossman et al., 1996) as well as in most melanomas
(Sundram et al., 2003). Importantly, IRF4 is associated with
human pigmentation (Sulem et al., 2007; Han et al., 2008), and
IRF4 expression correlates with MITF expression in melanoma
cells (Hoek et al., 2008). Here, we show that IRF4 is involved in
pigmentation, that the melanocyte master regulator MITF acti-
vates expression of the IRF4 gene, and that this activation
depends on the presence of the transcription factor activator
protein 2a (TFAP2A). A naturally occurring sequence variant
associated with human pigmentation overlaps the TFAP2A-
binding site, impairs binding by this transcription factor, and
consequently, lowers induction of IRF4 expression. Together,
the MITF and IRF4 proteins cooperatively activate expression
of the gene encoding the pigmentation enzyme Tyrosinase
(TYR). This activation depends on MITF- and IRF4-binding sites
in the TYR promoter. Thus, we have established a direct linkCbetween a polymorphism in an intron in the IRF4 gene and
reduced expression of an enzyme essential for pigmentation.
RESULTS
Fine Mapping of the IRF4 Locus Implicates rs12203592
as a Functional Variant Affecting Pigmentation
Several sequence variants in the IRF4 locus have been associ-
ated with freckling, sun sensitivity, eye and hair color, and with
nevus counts, with rs12203592-[T/C] showing the strongest
association (Sulem et al., 2007; Han et al., 2008; Duffy et al.,
2010a). The rs12203592-T minor allele is most common in indi-
viduals of European descent; it is not seen in sub-Saharan
Africans or in East Asians (see Figure S1 available online). Anal-
ysis of sequenced vertebrate species shows that this position is
occupied by C, suggesting that it is the ancestral allele.
In order to fine map the pigmentation trait associations at the
IRF4 locus, we used whole-genome sequencing data derived
from 2,230 Icelanders sequenced to an average coverage of at
least 103. This yielded approximately 38.5million SNP and small
indel (insertion or deletion) variants genome wide, 16,280 of
which were located in the region around IRF4 (0–1 Mb on chro-
mosome 6). Using imputation assisted by long-range haplotype
phasing (Kong et al., 2008, 2009; Holm et al., 2011), we deter-
mined the genotypes of these 16,280 variants in 95,085 individ-
uals who had been typed using Illumina SNP chips. We then
tested each variant for association with eye color, hair color,
freckling, and sun sensitivity, observing numerous significant
signals (Figure 1). The strongest signals in the IRF4 region
came from the association of rs12203592-T with presence of
freckles, brown hair, and high sensitivity of skin to sun exposure
(Figure 1; Table S1). The second-most significant variant associ-
ationwas for rs62389424-Awith freckles (p = 1.13 1081), nearly
40 orders of magnitude less significant than the corresponding
signal from rs12203592-T (p = 2.0 3 10120). The rs62389424
variant is correlated with rs12203592 with an r2 of 0.65. Two
other SNPs in the region have r2 values in excess of 0.2 with
rs12203592, and they also gave association signals with similar
phenotypes (Table S2). When, in a multivariate analysis, the
associations were conditioned on the effect of rs12203592, the
signals from the three correlated SNPs became nonsignificant
(Table S2). Indeed, once rs12203592 was taken into account in
the multivariate analysis, no variant in the IRF4 region retained
a significant signal after Bonferroni correction for the number
of tests (Figure 1). We note in this context that the signal from
the originally reported pigmentation variant at this locus,
rs1540771-T (Sulem et al., 2007), was also captured by
rs12203592 (Table S2). Thus, the associations at the IRF4 locus
with freckles, hair color, sun sensitivity, and eye color could all be
accounted for by rs12203592, and no other variant detected by
sequencing explains the effect with a similar level of significance.
Intron 4 of IRF4 Contains a Melanocyte-Specific
Enhancer Element
rs12203592 is located in intron 4 of the IRF4 gene, suggesting
that this SNPmight alter the function of a cis-regulatory element.
Data from the ENCODE consortium (Thurman et al., 2012) show
that rs12203592 overlaps a peak of DNase I hypersensitivityell 155, 1022–1033, November 21, 2013 ª2013 Elsevier Inc. 1023
Figure 1. Association of SNPs in the IRF4 Region with Pigmentation
Phenotypes
Association with pigmentation traits of variants in the IRF4 region (0–1 Mb on
chromosome 6) was determined by whole-genome sequencing and imputa-
tion into SNP chip-typed individuals. Black points show the unadjusted
association values; yellow points show association values adjusted for the
effect of rs12203592. The x axis is the genomic coordinate (hg18 Build 36). The
y axes are the association-log10 p values for sun sensitivity (yes/no, upper
panel), brown versus blond hair color (second panel), and freckling (yes/no,
third panel). The position of rs12203592 is indicated. The fourth panel shows
the local recombination (Recomb) rates in cM/Mb. The lowest panel indicates
the locations of known genes in the region, from UCSC. See also Table S1 and
Figure S1.(HS), a property of active regulatory elements, in human primary
melanocytes and three human melanoma lines (Figure 2A).
Moreover, rs12203592 does not overlap a DNase I-HS peak in
158 of 165 (96%) non-melanocyte-derived cell types examined
by ENCODE, suggesting that the regulatory activity in this region
is specific to the melanocyte lineage. In a subset of 49 ENCODE
cell types assayed by the Crawford group (Duke University) for
both DNase I-HS and global gene expression, IRF4 is expressed
at high levels only in cell types of melanocyte (n = 3) and lympho-
cyte origin (n = 8). The corresponding patterns of DNase I HS in
these cell types suggest that IRF4 expression in lymphocytes
and melanocytes is directed by distinct sets of regulatory
elements (Figure 2B). In addition, the position orthologous to
rs12203592 in the mouse genome directly overlaps a melano-
cyte enhancer (Gorkin et al., 2012) because it is occupied by
p300 and marked by H3K4me1 in the melanocyte line melan-
Ink4a-Arf (Sviderskaya et al., 2002) (Figure 2C).
To confirm that the intronic sequence containing rs12203592
acts as a melanocyte-specific enhancer, we subcloned a
450 bp fragment containing the rs12203592-C allele upstream
of a minimal promoter that drives luciferase expression and
assayed its activity in both the mouse melan-Ink4a-Arf and1024 Cell 155, 1022–1033, November 21, 2013 ª2013 Elsevier Inc.human SK-MEL-28 cell lines. The fragment showed strong
enhancer activity, directing >35-fold-higher luciferase expres-
sion than the minimal promoter alone in melan-Ink4a-Arf,
and >200-fold in SK-MEL-28 (Figures 3A and 3B). We next asked
whether the genotype at rs12203592 affects enhancer activity.
In both melan-Ink4a-Arf and SK-MEL-28, the presence of the
rs12203592-T allele significantly reduced the enhancer activity
of the fragment (p < 0.008) (Figures 3A and 3B).
We further assayed the sequence containing rs12203592
in vivo using transgenic zebrafish. We engineered a vector
containing the entire human IRF4 intron 4 sequence upstream
of a minimal promoter and the gene encoding GFP. We created
two versions of the vector, with either the T or C allele at
rs12203592; as above, the remainder of the sequence was iden-
tical in both constructs. We injected these constructs, or a nega-
tive control construct lacking any humangenomic sequence, into
zebrafish embryos at the two-cell stage, incubated them 48 hr
postfertilization, and scored them for the presence of GFP-posi-
tive cells. In embryos injectedwith the negative control construct,
we did not detect GFP-positive melanocytes (0 out of 40
embryos) (Figure 3C). In embryos injected with the IRF4 intron 4
reporter construct containing the ancestral rs12203592-C allele,
wedetectedGFP-positivemelanocytes in about 20%of embryos
(8 out of 40 embryos; 17 melanocytes total from the 8 embryos),
consistent with the mosaicism expected in transient transgenic
embryos (Figures 3C and 3D). By contrast, in embryos injected
with the reporter containing rs12203592-T, only 9% of the
embryos had detectable GFP-positive melanocytes (4 out of 44
embryos; only six melanocytes total). The difference in the total
number of melanocytes is statistically significant (p = 0.0023,
unpaired t test). We did not detect expression in other tissues,
beyond transient, scattered expression, which was seen in all
three constructs and has been reported by others (Bessa et al.,
2009). We conclude that IRF4 intron 4 contains a melanocyte
enhancer, likely directing IRF4 expression in these cells, and
that the rs12203592-T allele reduces the activity of this enhancer.
MITF Activates IRF4 Gene Expression
Chromatin immunoprecipitation sequencing (ChIP-seq) and
gene expression studies have suggested that MITF may be
involved in regulating IRF4 gene expression (Hoek et al., 2008,
Strub et al., 2011). We analyzed Irf4 expression in mice lacking
Mitf and focused on the heart because cells that normally ex-
pressMitf are still present in the heart ofMitfmi-vga9 homozygous
mutants, whereas melanocytes are absent resulting in white
coat color (Hodgkinson et al., 1993). Irf4 gene expression was
dramatically reduced in Mitf mutants compared to wild-type
controls (Figure 4A), consistent with the possibility that Irf4 is
regulated by MITF. To determine whether IRF4 is a target of
MITF in the melanocyte lineage, we used shRNA to knock
downMITF and IRF4mRNAs in human 501mel melanoma cells,
which normally express these genes. Transfecting these cells
with shRNA directed againstMITF reducedMITFmRNA expres-
sion to 45% (Figure 4B) and MITF protein levels to 41% (Figures
4C and S2) of those seen in untreated cells or cells treated
with a scrambled control shRNA. In cells treated with shMITF,
the expression of IRF4 mRNA and protein was dramatically
reduced (to 50% and 25%, respectively). shRNA against IRF4
Figure 2. rs12203592 Disrupts a Conserved Melanocyte Enhancer at IRF4
(A) UCSC genome browser view shows 25 kb region around IRF4 (hg19 coordinates chr6:388,750–413,750). DNase-seq signal (orange) in human epidermal
melanocytes, Colo829, Mel 2183, and RPMI-7951 was generated by ENCODE.
(B) Top view is a graph showing IRF4 expression level as measured by ENCODE in 49 cell types (Duke Affymetrix exon arrays). Bottom is the UCSC genome
browser view of 25 kb region around IRF4 (hg19 coordinates chr6:388,750–413,750) in corresponding cell lines.Melanocyte-specific DNase HS peak overlapping
rs12203592 is labeled ‘‘M,’’ lymphoid-specific DNase HS peaks are labeled ‘‘L,’’ and DNase HS overlapping the IRF4 promoter is labeled ‘‘P.’’ Cell types shown
are (top to bottom) human epidermal melanocytes, Colo829, Mel 2183, GM12878, GM12891, GM12892, GM19238, GM19238, GM19240, GM18507, and CLL.
(C) UCSC genome browser view shows 25 kb region around Irf4 (mm9 coordinates chr13:30,838,000–30,863,000). The ChIP-seq signals for EP300 (green) and
H3K4me1 (blue) in the mouse melanocyte line melan-Ink4a-Arf are from Gorkin et al. (2012).resulted in reduction in IRF4 mRNA and protein expression to
40% and 20% of control levels, respectively, whereas MITF
expression was unaffected (Figures 4C and S2). The expression
of DCT (encoding Dopachrome tautomerase) and TYR, two
known MITF target genes (Yasumoto et al., 1994, 2002), was
also reduced upon shMITF treatment, whereas shIRF4 treatment
only affected the expression of TYR (Figure 4B). TYR protein
expression was reduced upon treatment with shMITF, shIRF4,
and shAP2A, as well as with all shRNAs together (Figure S2).
Knocking down TFAP2A did not affect MITF expression.
We also tested this relationship in an overexpression assay.
Untransfected 501mel melanoma cells express MITF but low
levels of both TYR and IRF4 mRNAs, whereas HEK293T cells
do not express MITF endogenously and also lack expression
of TYR and IRF4. In both cell lines, overexpression of mouse
Mitf (mMitf) strongly induced the levels of TYR and IRF4 (Fig-
ure 4D). Analysis of the expression of MITF and IRF4 in 22
melanoma cell lines revealed a positive correlation between
MITF and IRF4 (p = 0.0003, Pearson correlation coefficient, Fig-
ure S3A). These results indicate that MITF directly or indirectly
regulates IRF4 expression. They also suggest that TYR expres-
sion depends on IRF4.Crs12203592 Alters the Function of a Melanocyte
Enhancer in IRF4 through Disruption of a
TFAP2A-Binding Site
The rs12203592 polymorphism is located 66 bp from three sites
recently shown to be occupied by MITF in ChIP-seq studies
(Figure 5A) (Strub et al., 2011). ChIP performed in 501mel and
MITF-transfected 293T cells showed that MITF binds to intron
4 of IRF4 (Figure 5B). Interestingly, the rs12203592-T polymor-
phism occurs in a predicted binding site (GGCAAA) for TFAP2A
(Do et al., 2010), which was recently shown to be involved in me-
lanocyte differentiation in zebrafish (Van Otterloo et al., 2010). To
determine if TFAP2A can bind this sequence, we performed anti-
TFAP2A ChIP in 501mel cells (homozygous for rs12203592-C)
and showed that TFAP2A binds to the intron 4 element in the
IRF4 gene (Figure 5C). Furthermore, gel shift assays showed
that TFAP2A binds oligos carrying the TFAP2A motif from IRF4
intron 4 only when the oligos harbor the rs12203592-C allele. It
did not bind the rs12203592-T variant, nor when the binding
site was altered completely (Figure 5D). Addition of antibody re-
sulted in a supershift only in the presence of the wild-type oligo.
Binding of MITF to the neighboring MITF sites was not affected
by the SNP (Figure S3B). These results show that TFAP2A bindsell 155, 1022–1033, November 21, 2013 ª2013 Elsevier Inc. 1025
Figure 3. Intron 4 of IRF4 Drives Expression
in Melanocytes
(A and B) Results of the luciferase assays inmelan-
Ink4a-Arf and SK-MEL-28 cells are shown. Pr,
promoter; Luc, luciferase reporter gene; IRF4 enh,
450 bp fragment from the fourth intron of IRF4
containing rs12203592. ‘‘IRF4 enh’’ fragments are
identical except for the base at position
rs12203592 as indicated (‘‘C’’ is the ancestral
allele; ‘‘T’’ is the derived allele). The x axis shows
fold luciferase activity relative to the minimal pro-
moter alone, which is normalized to one (1). p
values are calculated by Kolmogorov-Smirnov
test. The result is also highly significant by other
nonparametric tests (p = 0.007937 by Wilcoxon
rank sum test for both melan-Ink4a-Arf and SK-
MEL-28) and by the standard parametric t test (p =
0.001686 for melan-Ink4a-Arf; p = 0.01032 for SK-
MEL-28). Each bar represents the average of five
biological replicates per reporter construct. Error
bars represent SD.
(C) Reporter constructs contain either the
rs12203592-C version of the IRF4 intron 4 ele-
ment (IRF4) or the rs12203592-T version (IRF4snp)
upstream of the GFP reporter after injection into
zebrafish. The numbers represent the number of
melanophores (blue) and embryos (red) seen to be
positive (pos.) for GFP. The difference between
the melanophores containing the wild-type allele
of intron 4 of IRF4 compared to the mutant allele
(rs12203592) is statistically significant (*p =
0.0023, unpaired t test).
(D) Image shows a GFP-positive zebrafish embryo
with a GFP-positive melanophore in the inset.the ancestral sequence (rs12203592-C) in intron 4 of IRF4 but
fails to bind to the rs12203592-T variant.
To determine if TFAP2A plays a role in the activity of the IRF4
enhancer, we performed reporter assays using intron 4 of IRF4
as regulatory element. 501mel melanoma cells were cotrans-
fected with the reporter constructs and with plasmids encoding
MITF, TFAP2A, or both. Neither MITF nor TFAP2A alone elevated
expression from this element above basal levels (Figure 5E).
However, when both MITF and TFAP2A were expressed
simultaneously, transcription was increased 6-fold (Figure 5E),
suggesting that the proteins have cooperative effects on
the activity of this enhancer. This is further supported by
theshRNAexperiments that showed that knockingdownTFAP2A
reduces IRF4 expression (Figures 4B and 4C). Removing all three
MITF-binding sites together (intron 4-3xE) led to background-
level expression (Figure 5E). Importantly, when the rs12203592-
T variant was introduced into the reporter construct (intron 4-rs),
the cooperation seen between MITF and TFAP2A was reduced
to levels close to background (Figure 5E). This suggests
that MITF requires TFAP2A in order to induce expression from
the intron 4 element and that the rs12203592-T polymorphism
abolishes the MITF-mediated activation.1026 Cell 155, 1022–1033, November 21, 2013 ª2013 Elsevier Inc.To determine whether the rs12203592-
T variant affects IRF4 expression in mela-
nocytes, RNA and protein were isolatedfrom melanocytes differentiated from human neonatal foreskin
melanoblasts from Australian subjects (Cook et al., 2009).
RT-qPCR showed a significantly lower (p < 0.01, unpaired
t test) expression of IRF4 mRNA in cells homozygous for the
rs12203592-T polymorphism than in cells homozygous for the
ancestral C (Figures 5F and S3C). IRF4 protein levels in cells
from T/T individuals were considerably reduced compared to
that of cells from C/C individuals (Figure 5G).
To determine whether the rs12203592 polymorphism affects
expression of the transcript on the chromosome on which the
variation resides, we used an allele discrimination assay. We
used RT-qPCR on human primary melanocytes heterozygous
for the IRF4 30 UTR SNP rs872071-A/G. The rs872071-G allele
resides 15 kb distal to rs12203592 and is present on the haplo-
type on which the rs12203592-T allele arose, thus allowing for
comparison of IRF4 allele-specific expression levels, controlling
for potential transfactor variations that may contribute to expres-
sion level differences between individuals. We observed no
difference in IRF4 allelic expression in rs12203592-C/C
homozygous melanocytes, as represented by the rs872071-A/
G allele ratio (Figure S4). In contrast, cells heterozygous for
the rs12203592 C/T alleles exhibit a significantly higher
Figure 4. MITF Regulates Expression of IRF4
(A) The expression of the Mitf and Irf4 mRNAs is reduced in hearts from Mitfmi-vga9 mutant mice, as determined by qPCR analysis. Data are represented as
mean ± SEM.
(B) Expression of the MITF, IRF4, TFAP2a, DCT, and TYR genes upon treatment with shRNA against MITF, IRF4, TFAP2A, and negative control in 501mel
melanoma cells as determined by qPCR analysis is shown. Data are represented as mean ± SEM.
(C) Western blot shows expression of the MITF, TFAP2A, IRF4, and b-actin proteins in 501mel cells after shRNA treatment. Intensity quantification is relative to
actin-loading control. See also Figure S2.
(D) Overexpression of the mouse Mitf (mMitf) cDNA (expressed from pcDNA3.1) in 501mel melanoma cells and in HEK293T embryonic kidney cells affects
expression of the TYR and IRF4 mRNAs as assayed by RT-qPCR, whereas b-actin expression is unchanged. mMitf was detected with species-specific primers
that only recognize the mouse Mitf gene. See also Figure S3.
See also Figure S2 and Table S3.rs872071-A/G allele ratio (p < 0.01), consistent with reduced
transcription occurring from IRF4 rs872071-G alleles in phase
with rs12203592-T.
Several alternate products are made from the IRF4 gene,
including transcripts that initiate in intron 4 (Figure S5A), leading
to an mRNA containing internal ATGs (lacking Kozak consensus
sequences) and the tentative production of a truncated protein
lacking the N-terminal DNA-binding domain. To determine the
major product in the melanocyte, RT-qPCR analysis with tran-
script-specific primers was performed on RNA isolated from
foreskin melanoblasts from Australian subjects. This showed
that themajor IRF4 product in melanocytes is the full-length tran-
script; the smaller alternative product was barely detectable
(Figure S5B). Similarly, in mouse melanoblasts isolated from
E15.5 and E17.5 embryos and melanocytes from P1 and P7
neonatal pups (Debbache et al., 2012), the full-length Irf4 tran-
script was the only transcript detected at all developmental
stages (Figure S6). We therefore conclude that the regulatory
element in intron 4 affects the production of the full-length
IRF4 transcript.CIRF4 and MITF Cooperatively Regulate TYR Expression
To determine how IRF4 levels might affect pigmentation, we
searched the promoter sequences of several pigmentation genes
for the IRF4-binding motif. Several potential IRF4-binding motifs
were found in the TYR promoter, on either side of known MITF-
binding sites previously shown to be essential for gene activation
(Figure 6A) (Yasumoto et al., 1994; Bertolotto et al., 1996). To
investigate the relationship between IRF4 and the expression of
several pigmentation genes, two human melanocyte strains
with high expression of IRF4 were independently transfected
with siRNA targeting IRF4 for 48 hr, followed by total RNA extrac-
tion andRT-qPCR. These results combined show that expression
of IRF4 was reduced on average to 40% of cells treated with
negative control siRNA (Figure 6B). Interestingly, the expression
of TYR was reduced to 50% compared to untreated control,
whereas the expression of the pigmentation genes SLC45A2
(MATP), SLC24A5, and DCT was largely unaffected (Figure 6B).
Similarly, knockdown of IRF4 affected expression of TYR but
not of DCT in 501mel melanoma cells (Figures 2B and 2C). This
suggests that IRF4 is involved in regulating TYR expression butell 155, 1022–1033, November 21, 2013 ª2013 Elsevier Inc. 1027
Figure 5. MITF and TFAP2A Affect IRF4 Expression by Binding Regulatory Elements in Intron 4
(A) Schematic view presents the IRF4 gene. The sequence shows a comparison of MITF- and TFAP2A-binding sites in intron 4 of IRF4 among humans (H sap
[Homo sapiens]), gorilla (G gor [Gorilla gorilla]), chimpanzee (P tro [Pan troglodytes]), and mouse (M mus [Mus musculus]). The location of the rs12203592
polymorphism is indicated.
(B) ChIP analysis of a GST-taggedMITF protein (a-GST AB) was performed in 501mel cells. Primers specific for HSPA1B (negative control), TYR (positive control),
and intron 4 of IRF4 are indicated. The GST-tagged Mitf only precipitated TYR and IRF4 sequences.
(C) ChIP analysis of TFAP2A in 501mel cells is presented. PCR products specific for TGFA (positive control), HSPA1B (negative control), and intron 4 of IRF4 are
shown. TFAP2A only precipitated TGFA and INT4 sequences.
(D) Gel shift analysis shows the binding of TFAP2A to the ancestral sequence (INT4-WT) in intron 4 of IRF4 (coordinates chr6: 396309–396333 in build GRCh37.p5
of the human genome), but not to the rs12203592-T sequence (INT4-RS) or to a completely mutated sequence (INT4-mut).
(E) Luciferase reporter assays were performed in 501mel melanoma cells using intron 4 of IRF4 as a reporter. The ancestral IRF4 intron 4 sequence (intron 4,
blue), the rs12203592-T polymorphic sequence (intron 4-rs), a sequence where all MITF-binding sites were mutated (intron 4-3xE), and a sequence containing
mutated MITF sites and the rs12203592-T polymorphism (intron 4-3xE+rs) were tested. The luciferase reporters were cotransfected with the wild-type MITF
and TFAP2A proteins and with a dominant-negative version of MITF (MITFmi). Statistical analysis was done using unpaired t test. Data are represented as
mean ± SEM.
(F) Cells homozygous for the ancestral allele (CC) express significantly higher levels of IRF4 than cells homozygous for the rs12203592-T polymorphism (TT). Fold
expression data are represented relative to pooled mean TT expression ± SEM. Statistical analysis was performed using ANOVA (***p < 0.001).
(G) A western blot shows expression of the IRF4 protein in melanocytes from CC and TT individuals. Intensity quantification is relative to GAPDH-loading control.
Note the decrease of basal IRF4 protein in the TT melanocyte cell lines.
See also Figures S3, S4, and S5.does not affect expression of SLC45A2 or SLC24A5. The expres-
sionof IRF4correlateswith theexpressionof TYR in22melanoma
cell lines (p = 0.0007, Pearson correlation coefficient, Figure S3A).
Cotransfection assays in HEK293T cells (which do not express
MITF) showed that, whereasMITF can activate expression of the1028 Cell 155, 1022–1033, November 21, 2013 ª2013 Elsevier Inc.TYR gene, the IRF4 protein is unable to do so on its own (Fig-
ure 6C). However, in the presence of both MITF and IRF4, coop-
erative effects were observed with increasing amounts of IRF4
(Figure 6C). A mutant MITF protein with defective DNA-binding
ability resulted in less activation and reduced cooperativity
Figure 6. MITF and IRF4 Regulate Expression of TYR
(A) Schematic view of the human TYR promoter shows the sequence of the
MITF and potential IRF4-binding sites.
(B) Expression of IRF4, TYR, MATP, SLC24A5, and DCT was determined by
qPCR, after treatment with siIRF4 or control siRNAs. Fold expression of each
gene is represented relative to cells transfected with negative siRNA (arbitrarily
set to one [1]). Data represent the mean ± range of two experiments using two
primary melanocytes (QF1438 and QF1424).
(C) Luciferase reporter assay used wild-type TYR promoter as reporter
construct and cotransfected with constructs expressing the MITF and IRF4
proteins. Statistical analysis was performed using the t test; data are repre-
sented as average with the SD.
C(Figure S7A). Similar effects were observed when the E box was
mutated (Figure S7B), confirming that the cooperativity is medi-
ated through MITF. Quantitative ChIP experiments in Skmel28
(Figure 6D) and Skmel5 (Figure S7C) melanoma cells showed
that IRF4 binds the proximal TYR promoter as well as a more
distant region.
Irf4 Affects Pigmentation in Mice
No pigment phenotypes were reported in mice with a targeted
deletion of Irf4 (Mittru¨cker et al., 1997). We analyzed the expres-
sion of Mitf, Tfap2a, Irf4, and Tyr in melanoblasts isolated from
E15.5, E17.5, P2, and P7 mouse embryos (Debbache et al.,
2012). Mitf and Tfap2a are both expressed at the embryonic
and postnatal stages, whereas Irf4 is detected at a low level at
the two postnatal stages (Figure 7A). Tyr is expressed at all
stages, but the level of expression increases at the postnatal
stages and is 10-fold higher at P7 than at the earlier stages (Fig-
ure 7A). This expression pattern is consistent with our data that
MITF and TFAP2A regulate IRF4 expression, and MITF and
IRF4 regulate TYR expression. Because early stages of develop-
ment do not express Irf4, this also suggests that IRF4 is mostly
involved in melanocyte differentiation. To determine if Irf4 plays
a role in mouse melanocytes, mice carrying an Irf4-flox cassette
(Irf4 f) (Klein et al., 2006) were crossed to mice expressing the
Cre-recombinase under control of the Tyr promoter (Tyr::Cre)
(Delmas et al., 2003). This led to the lack of Irf4 expression in
Tyr-expressing cells, but no apparent pigmentation phenotype,
similar to the Irf4 null mice (Mittru¨cker et al., 1997). In order to
test the relationship between Mitf and Irf4 in the mouse, we
crossed the Tyr::Cre/0; Irf4 f/f mice to mice carrying the domi-
nant-negative allele MitfMi-White (MitfMi-Wh). Mice heterozygous
for this allele (MitfMi-Wh/+) have a partial deficiency of Mitf and
exhibit a stable, gray coat color with white belly spot. Interest-
ingly, the Tyr::Cre/0; Irf4 f/f; MitfMi-Wh/+ mice showed distinctly
lighter coat color than seen inMitfMi-Wh/+ mice, which are nega-
tive for the Tyr-Cre transgene (Irf4 f/f; MitfMi-Wh/+) (Figure 7B).
This confirms that IRF4 plays a role in mouse pigmentation, like
in humans, and that the effects of Irf4 in the mouse also depend
on Mitf. In humans, the IRF4 variant rs12203592-T is linked to
brown hair color (Sulem et al., 2007) (Table S1). Thus, reduced
IRF4 expression alone is sufficient for lighter hair color in hu-
mans, whereas in mice, MITF function also needs to be reduced
to see effects on pigmentation. This suggests that there may be
species-specific differences betweenmice and humans in terms
of the requirement forMITF and IRF4 in melanocytes of the hair.(D) IRF4 binds the TYR locus. ChIP real-time PCR (ChIP-qPCR) analysis shows
IRF4 binding at sites proximal (around transcription start site; pTYR) and more
distal (1,800 bp upstream of transcription start site; dTYR) to TYR-coding
region and other control loci in SK-MEL-28 melanoma cell line and in negative
control OCI-Ly-19, a germinal center type B cell lymphoma (GCB-DLBCL) cell
line previously shown to lack IRF4 expression (Yang et al., 2012). Primer pair
amplifying a region upstream of the SUB1 locus was used as a positive control
because this region showed strong IRF4 binding both in multiple myeloma
(Shaffer et al., 2008) and activated B cell-type B cell lymphoma (Yang et al.,
2012) cell lines. NegA is a region on chromosome 7, used as a negative control
for IRF4 binding, due to the lack of observable IRF4 binding in previous studies
with multiple myeloma and ABC-DLBCL cell lines. Error bars depict SEM.
See also Figure S7.
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Figure 7. IRF4 Is Involved in Regulating Pigmentation in Mice
(A) The expression plot shows the presence and clear differences in the expression ofMitf, Tcfap2a, Irf4, and Tyr at different developmental time points, E15.5,
E17.5, P1, and P7, measured in FPKM. Indicated expression levels of a transcript are proportional to the number of reads sequenced from that transcript after
normalizing for respective transcript’s length. RNA from E15.5 embryos is shown in blue bars, E17.5 embryos in red, P1 pups in green, and P7 in violet.
(B) Mice where Irf4 has been conditionally knocked out in heterozygotes for the semidominantMitfMi-Whmutation are presented.MitfMi-Wh heterozygotes that are
simultaneously lacking Irf4 show lighter coat color (left) than mice that are wild-type for Irf4 (right).
(C) Model depicts the relationship amongMITF, TFAP2A, and IRF4 in melanocytes and their effects on the expression of TYR. MITF and TFAP2A bind together to
the intron 4 element in the IRF4 gene and regulate the expression of IRF4 from the upstreampromoter. MITF and IRF4 then bind to and activate expression of TYR,
leading to normal pigmentation. The rs12203592-T polymorphism leads to reduced IRF4 activation and thus reduced TYR expression, which consequently leads
to sun sensitivity and blue eyes.DISCUSSION
GWASs have yielded a long list of sequence variants
correlated with a wide range of human phenotypes. Most of
these variants are located in noncoding regions of the genome
and do not alter the amino acid sequence of proteins or
have known regulatory functions. Two steps are essential in1030 Cell 155, 1022–1033, November 21, 2013 ª2013 Elsevier Inc.order to characterize the biology behind such associations.
First, the association signals must be fine mapped using
full sequence data. Second, the biological processes
involved must be unraveled experimentally. In this study, we
have taken both steps to shed light on the functional con-
sequences of the IRF4-noncoding variant rs12203592 on
pigmentation.
Our work proposes a model describing how IRF4 acts in
cooperation with MITF to influence pigmentation phenotypes
(Figure 7C). In melanocytes, MITF and TFAP2A cooperatively
activate IRF4 expression through an enhancer element in intron
4. In turn, IRF4 and MITF cooperate to activate transcription of
TYR. The rs12203592-T allele reduces binding of TFAP2A to its
cognate site in intron 4 of IRF4, thereby suppressing the induc-
tion of IRF4 expression and, as a consequence, impairing the
cooperative induction of TYR. This leads to the pigmentation
phenotypes associated with the rs12203592-T allele. The effects
of this variant must be cell-type specific because Do et al. (2010)
have shown that it leads to increased IRF4 promoter activity in
Burkitt lymphoma B cells (Raji), HEK293T human embryonic kid-
ney cells, and the NCI-H295R human adrenal cells. Consistent
with our results, they showed that TFAP2A binds with higher
affinity to the C allele than to the T allele (Do et al., 2010). Thus,
the cell-type-specific effects must be mediated by transcription
factors other than TFAP2A.
In humans, genetic variants in different genes have particular
effects on pigmentation traits. For example,MC1R andASIP var-
iants havemajor effects on freckling, sun sensitivity, and red hair,
whereas they have relatively little effect on eye color (Sulem
et al., 2007, 2008). The rs12203592-T variant of IRF4 also has
major effects on freckling and sun sensitivity but is associated
with brown (over blond) hair and has a notable effect on eye color
(Table S1). The results presented here suggest that IRF4, like
MC1R and ASIP, exerts its major effects on pigmentation traits
through the master regulator MITF. However, some divergence
in pathways must occur in order to account for the differences
in effects on pigmentation traits. We have shown that TYR is a
target of MITF-IRF4 cooperative activation. However, TYRP1
and DCT are targets of MITF activation that do not appear to
be responsive to IRF4. Clearly, the MITF-IRF4 cooperation only
occurs in a subset of MITF-responsive genes. A broader search
of MITF target genes for potential IRF4 responsiveness might
shed light on the pattern of pigmentation traits affected by IRF4.
Freckles represent clusters of concentrated melanin in the
skin, without an increase in melanocyte numbers. Freckles are
either light brown or red but usually become darker and more
visible upon exposure to sunlight. GWASs have shown that var-
iations in MC1R, ASIP, TYR, and BNC2, in addition to IRF4, are
associated with freckles (Sulem et al., 2007, 2008; Eriksson
et al., 2010). Mutations in theMC1R gene have been highly asso-
ciated with the formation of freckles (Bastiaens et al., 2001). In
addition to regulating TYR and IRF4 gene expression, MITF is
also known to regulate expression of MC1R (Adachi et al.,
2000; Smith et al., 2001; Aoki and Moro, 2002). This suggests
the possibility that, like with TYR, IRF4 cooperates with MITF in
regulating expression of MC1R in melanocytes. Indeed, ChIP-
seq studies show that MITF binds MC1R regulatory sequences
(Strub et al., 2011).
The effects of both TFAP2A and IRF4 are mediated through
MITF, which is needed both for the TFAP2A-mediated activation
of IRF4 and the IRF4-mediated activation of TYR. ChIP-seq
studies suggest that MITF regulates TFAP2A as well as IRF4
(Strub et al., 2011). The cooperative effects of MITF and IRF4
suggest that these proteins might physically interact on the
TYR promoter. TFAP2A is expressed in a variety of both mesen-Cchymal and epithelial cell types. It is not known how MITF and
TFAP2A interact in the regulation of IRF4. Because the binding
sites are physically close to each other, it is possible that both
proteins are part of a larger complex formed at the site. Together,
these data suggest that transcription factors that are expressed
in multiple cell types can form cell-type-specific complexes to
govern differentiation.
Several studies have shown that polymorphisms identified as
susceptibility loci in GWASs affect the binding of particular
transcription factors, in some cases, leading to differences in
expression of a nearby target gene (Meyer et al., 2008; Rahimov
et al., 2008; Pomerantz et al., 2009; Scho¨del et al., 2012; Tuupa-
nen et al., 2009). However, the effects of the gene expression dif-
ferences have not been characterized, andmore importantly, the
biological effects on the phenotype are only implied in these
studies. A recent example is provided by the rs12913832 poly-
morphism in intron 86 of the HERC2 gene, which shows a strong
association with human eye color and pigmentation. Because
the pigment gene OCA2 is located 21 kb downstream of
HERC2, it has been speculated that this polymorphism is located
in a distal regulatory element of OCA2 and may affect binding of
the transcription factors HLTF, LEF1, and MITF (Visser et al.,
2012). This results in the formation of a loop between the
HERC2 enhancer and the OCA2 promoter, thus affecting
OCA2 expression. The rs12913832-C allele prevents HLTF
from binding to the element, thus reducing loop formation. The
regulation of OCA2 expression may be more complex, however,
with separate regulatory elements responsible for eye and skin
color (Beleza et al., 2013). Here, we have gone one step further
and shown the effects of transcription factor binding on gene
expression and how this gene expression difference leads to
effects on human pigmentation.EXPERIMENTAL PROCEDURES
Whole-Genome Sequence Analysis
Icelandic Population Samples and Phenotypic Information
Icelandic adults were recruited as cases, family members, or controls through
a series of cardiovascular, oncology, neurology, and metabolic studies con-
ducted by deCODE Genetics. Blood samples were taken for DNA isolation
upon recruitment. The studies were approved by the National Bioethics Com-
mittee of Iceland and the Icelandic Data Protection Commission. Personal
identifiers associated with phenotypic information, blood samples, and geno-
types were encrypted using a third-party encryption system. Each participant
completed a questionnaire that included questions about natural eye color
categories (blue/gray, green, or black/brown), natural hair color categories
(red/reddish, blond, dark blond/light brown, or brown/black), and the presence
of freckles at any time. Sun sensitivity was assessed using the Fitzpatrick skin-
type score (Fitzpatrick, 1988), where the lowest score (I) represents very fair
skin that is sensitive to UVR, and the highest score represented in native Ice-
landers (IV) represents dark skin that tans rather than burns in reaction to UVR
exposure. Individuals scoring I or II were classified as being sensitive to sun,
whereas individuals scoring III and IV were classified as not being sensitive
to sun.
SNP ChIP Genotyping
The Icelandic chip-typed samples were genotyped with Illumina Human
Hap300, HumanHap CNV370, HumanHap 610, 1 M, Omni1-Quad, Omni 2.5,
or Omni Express bead chips at deCODE Genetics. SNPs were excluded if
they had (1) yield less than 95%, (2) minor allele frequency less than 1% in
the population, (3) significant deviation from Hardy-Weinberg equilibrium in
the controls (p < 0.001), (4) if they produced an excessive inheritance errorell 155, 1022–1033, November 21, 2013 ª2013 Elsevier Inc. 1031
rate (over 0.001), and (5) if there was a substantial difference in allele frequency
between the chip types (SNPs from a single-chip platform were excluded if
that resolved all differences but otherwise from all chip platforms). All samples
with a call rate below 97% were excluded from the analysis. For the Human-
Hap series of chips, 308,840 SNPswere used for long-range phasing, whereas
for the Omni series of chips, 642,079 SNPs were included. The final set of
SNPs used for long-range phasing was composed of 785,863 SNPs.
Whole-Genome Sequencing and Imputation
Sequence data were obtained from about 2,230 Icelanders using methods
described previously by Holm et al. (2011). Sequencing was carried out to
an average depth of at least 103. This resulted in the identification of approx-
imately 38.5 million SNPs and small indels that were available for imputation.
Long-range phasing, imputation, and association testing (by logistic regres-
sion) were done as described previously (Kong et al., 2008, 2009; Holm
et al., 2011; Stacey et al., 2011). For conditional analysis of the IRF4 region,
the rs12203592-T allele count of each individual was given as a covariate in
the logistic regression.
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